You are here: Home » International » News » Companies
Business Standard

World Coronavirus Dispatch: Pandemic-driven changes a boon for Amazon

Moderna expects to make 3 billion doses by 2022, AstraZeneca struggles with data needed for vaccine's approval in US, and other pandemic-related news across the globe

Coronavirus | Coronavirus Tests | Coronavirus Vaccine

Akash Podishetty  |  Hyderabad 

Amazon reported a second straight quarter of $100 billion-plus revenue in the first three months of the year

Amazon continued to benefit from the pandemic-driven changes like mass online shifting as it's earnings beat the estimates of Wall Street by some distance. The company reported a second straight quarter of $100 billion-plus revenue in the first three months of the year, that is a 44 per cent rise from the year-ago period. Almost half Amazon’s operating income — $4.2 billion — came from its cloud division, Aamazon Web Services, whose business customers have been forced to invest as a result of the shift to homeworking. The net income more than tripled to $8.1 billion. Read here

Let's look at the global statistics

Global infections: 150,536,843

Global deaths: 3,165,999

Nations with most cases: US (32,288,909), India (18,762,976), Brazil (14,590,678), France (5,653,533), Russia (4,788,700).

Source: John Hopkins Coronavirus Research Center

AstraZeneca struggles with data needed for vaccine’s approval AstraZeneca's struggle to get its vaccine rolled out in United States continues as the officials are finding it hard to put together adequate data for its aproval by the drug regulator. The officials were said to have told the regulator that it needs time until mid-May to forward the application, delaying the earlier deadline of mid-April. Even though the US has more than enough approved vaccines to inoculate its citizens and doesn't have much need for AstraZeneca shot, the company hopes an approval by the Food and Drug Administration (FDA) will give boost to the confidence in vaccine in other countries across the world.

Read here Moderna boosting vaccine capacity Moderna, one of the three vaccines approved in the United States, has raised its production capacity forecast for its vaccine and expects to make 3 billion doses in 2022. This is more than double the previous estimate. It also said it is increasing its expectations for 2021 vaccine production to between 800 million and 1 billion shots. Moderna also said new data suggests its shots can be stored safely for up to three months at refrigerator temperatures, making it easier to get them to hard to reach areas that may not have access to freezers. Read here Millions at risk from Covid surge in Syria New wave of infections are threatening the health systems in Syria, a country which was already devastated by 10 years of war, collapsing the infrastructure, economy and health care systems. The United Nations and other health agencies have warned that the rapidly accelerating new wave could put millions of lives at risk, as the country doesn't have enough resources to do enough testing, effective contact tracing and so on.. There are also similar concerns about the health infra and experts warn, if the new trend of infections doesn't flatten, there may be acute shortage of Oxygen. Read here

Dear Reader,

Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor

First Published: Fri, April 30 2021. 12:01 IST